Granules India announces results for FY13
Its sales increases 17 per cent to Rs 764 crore; net profit increases nine per cent to Rs 33 crore
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
A paucity of perception
A fortnight after the Supreme Court of India delivered its judgment in the Novartis/ Glivec case
Access to medicines: Beyond 2Ps
While price and patents have for long been considered as the two barriers impeding access to medicines, the issue extends far…
‘Manufacturers should engage the USFDA early during drug approval for naming of a…
United States Pharmacopeia's new monograph naming policy is all set to come into effect by May this year. Srini Srinivasan,…
Orchid enters strategic partnership with Allecra Therapeutics
Company’s will assign IP pertaining to a lead antibiotic compound
Sun Pharma gets ANDA approvals for anti-diabetes drugs
Tentative approvals for ANDAs for sitagliptin tablets, metformin HCl extended-release tablets
Indoco receives ANDA approval for Glimepiride tablets from USFDA
The approval is for Glimepiride 1mg, 2mg and 4mg tablets which are prescribed for type-2 diabetes patients to enhance glycemic…